Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study

Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study

Abstract Background Post-contrast acute kidney injury (PC-AKI) is a severe complication of coronary angiography (CAG) and percutaneous coronary intervention (PCI). Currently, the effect of statins on PC-AKI and its mechanism remains unclear. Methods This multicenter retrospective observational study...

Full description

Bibliographic Details
Main Authors:	Maoning Lin, Tian Xu, Wenjuan Zhang, Duannbin Li, Ya Li, Xulin Hong, Yi Luan, Wenbin Zhang, Min Wang
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Series:	Lipids in Health and Disease
Subjects:	Post-contrast acute kidney injury Statins Lipid-lowering effect Anti-inflammatory effect Percutaneous coronary intervention Path analysis
Online Access:	https://doi.org/10.1186/s12944-021-01489-7

Similar Items

Comparison between rosuvastatin and atorvastatin for the prevention of contrast-induced nephropathy in patients with STEMI undergoing primary percutaneous coronary intervention
by: Ata Firouzi, et al.
Published: (2018-09-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

Long-Term Benefit and Withdrawal Effect of Statins After Percutaneous Coronary Intervention: A Nationwide Population-Based Cohort Study
by: Jeong HY, et al.
Published: (2020-04-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

Statins in clinical practice
by: A. S. Sivkov, et al.
Published: (2010-04-01)

European recommendations on therapy of dyslipidemias – 2016 Lipid-lowering therapy in patients with acute coronary syndrome and percutaneous coronary interventions
by: Y. A. Karpov, et al.
Published: (2016-12-01)

Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis
by: N. E. Gavrilova, et al.
Published: (2015-11-01)

Safe Limits of Contrast Media for Contrast-Induced Nephropathy: A Multicenter Prospective Cohort Study
by: Zhiqiang Nie, et al.
Published: (2021-08-01)

Gut bacterial microbiome composition and statin intake—A systematic review
by: Andreia M. Dias, et al.
Published: (2020-06-01)

Anemia as a risk factor of contrast-associated acute kidney injury
by: O. Iu. Mironova, et al.
Published: (2020-12-01)

Statins and the risk of cataract
by: E. K. Butina, et al.
Published: (2019-12-01)

Management of statin intolerance
by: Soma B Raju, et al.
Published: (2013-01-01)

Validation of pre-operative risk scores of contrast-induced acute kidney injury in a Chinese cohort
by: Wenjun Yin, et al.
Published: (2020-02-01)

A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography
by: Liwei Liu, et al.
Published: (2020-08-01)

Statin safety: myths and reality
by: Zh. D. Kobalava, et al.
Published: (2007-04-01)

Barriers for statin prescription in real-world clinical practice (results of a survey among Krasnodar City and Krasnodar Region doctors)
by: V. V. Skibitsky, et al.
Published: (2008-06-01)

The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis
by: Stergios Soulaidopoulos, et al.
Published: (2018-02-01)

Efficacy of atorvastatin on the prevention of contrast-induced acute kidney injury: a meta-analysis
by: Liu L, et al.
Published: (2018-03-01)

METABOLIC EFFECTS OF STATINS AND CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS
by: E. I. Yakovenko, et al.
Published: (2012-04-01)

Case Report and Literature Review on Low-Osmolar, Non-Ionic Iodine-Based Contrast-Induced Encephalopathy
by: Liu MR, et al.
Published: (2020-12-01)

The Role of Statins in Sepsis
by: Cansu GÖNCÜOĞLU, et al.
Published: (2021-09-01)

A network meta-analysis on comparative efficacy of statins focusing for prevention of contrast-induced acute kidney injury in chronic kidney disease patients undergoing percutaneus coronary intervention
by: Ilham Akbar Rahman, et al.
Published: (2019-12-01)

Contrast-induced acute kidney injury in patients with stable coronary artery disease: the most important risk factors and prevalence
by: O. I. Mironova, et al.
Published: (2020-10-01)

Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study
by: Salgaonkar V. Jaywant, et al.
Published: (2016-09-01)

Zero-contrast percutaneous coronary interventions to preserve kidney function in patients with severe renal impairment and hemodialysis subjects
by: Jerzy Sacha, et al.
Published: (2019-06-01)

Hydrophilic or Lipophilic Statins?
by: Elisenda Climent, et al.
Published: (2021-05-01)

Incidence, Risk Factors, and Outcomes of Contrast Associated Nephropathy following Percutaneous Coronary Intervention
by: Iqbal Wani, et al.
Published: (2020-01-01)

Contrast-induced acute kidney injury in chronic coronary artery disease patients with diabetes mellitus and obesity
by: O. Iu. Mironova, et al.
Published: (2020-11-01)

Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention
by: Jun-yi Zhang, et al.
Published: (2019-07-01)

Developmentand Validation of a Questionnaire about Patient Knowledge of Adverse Effects of Statins
by: Opančina Valentina, et al.
Published: (2016-12-01)

Association of prealbumin levels with contrast-induced acute kidney injury in elderly patients with elective percutaneous coronary intervention
by: You ZB, et al.
Published: (2018-04-01)

Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention
by: Ying Yuan, et al.
Published: (2017-01-01)

Statin treatment: myths and reality
by: L. A. Malay, et al.
Published: (2008-06-01)

Safety and Efficacy of Minimum- or Zero-Contrast IVUS–Guided Percutaneous Coronary Interventions in Chronic Kidney Disease Patients: A Systematic Review
by: Alexandru Burlacu, et al.
Published: (2021-05-01)

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
by: Armstrong SO, et al.
Published: (2019-08-01)

Statins in acute coronary syndrome
by: O. M. Drapkina
Published: (2009-10-01)

Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease
by: Olga Iu. Mironova, et al.
Published: (2020-10-01)

Are statins beneficial for the treatment of pulmonary hypertension?
by: Lei Wang, et al.
Published: (2017-12-01)

Statins and their antiarrhythmic activity
by: N. Sh. Zagidullin, et al.
Published: (1970-01-01)

Cannot write session to /tmp/vufind_sessions/sess_vf63boqihfuu69mtu7io5mjll1